A study found 26 DNA regions tied to fibromyalgia, showing the disorder originates in the brain’s pain circuits, not in ...
Despite regulatory progress in many countries, skepticism and a lack of robust randomized trials continue to limit the use of medical cannabis in rheumatology.
Sarah had fibromyalgia, a condition that affects nearly one in 20 people but remains frustratingly difficult to diagnose and, for many patients, even harder to have taken seriously.
Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...
Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment ...
People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...
When Lee woke one morning in 2008, a deep, unshakeable ache pinned her to the bed. She hadn't exercised, partied, or touched ...
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely and cool” stories on point-of-care AI use and the FDA approval of ...
Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announced today that Seth Lederman, M.D., Chief Executive Officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback